These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36115020)

  • 1. Direct Observation of "Elongated" Conformational States in α-Synuclein upon Liquid-Liquid Phase Separation.
    Ubbiali D; Fratini M; Piersimoni L; Ihling CH; Kipping M; Heilmann I; Iacobucci C; Sinz A
    Angew Chem Int Ed Engl; 2022 Nov; 61(46):e202205726. PubMed ID: 36115020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase separation and other forms of α-Synuclein self-assemblies.
    Poudyal M; Sakunthala A; Mukherjee S; Gadhe L; Maji SK
    Essays Biochem; 2022 Dec; 66(7):987-1000. PubMed ID: 36373662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid-liquid Phase Separation of α-Synuclein: A New Mechanistic Insight for α-Synuclein Aggregation Associated with Parkinson's Disease Pathogenesis.
    Mukherjee S; Sakunthala A; Gadhe L; Poudyal M; Sawner AS; Kadu P; Maji SK
    J Mol Biol; 2023 Jan; 435(1):167713. PubMed ID: 35787838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulating α-Synuclein Liquid-Liquid Phase Separation.
    Sawner AS; Ray S; Yadav P; Mukherjee S; Panigrahi R; Poudyal M; Patel K; Ghosh D; Kummerant E; Kumar A; Riek R; Maji SK
    Biochemistry; 2021 Dec; 60(48):3676-3696. PubMed ID: 34431665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis.
    Mehra S; Sahay S; Maji SK
    Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):890-908. PubMed ID: 30853581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity.
    Carija A; Pinheiro F; Pujols J; Brás IC; Lázaro DF; Santambrogio C; Grandori R; Outeiro TF; Navarro S; Ventura S
    Redox Biol; 2019 Apr; 22():101135. PubMed ID: 30769283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of the Conformational Dynamics of a DNA Hairpin by α-Synuclein in the Presence of Aqueous Two-Phase Systems.
    Mukherjee SK; Knop JM; Möbitz S; Winter RHA
    Chemistry; 2020 Aug; 26(48):10987-10991. PubMed ID: 32453478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium promotes α-synuclein liquid-liquid phase separation to accelerate amyloid aggregation.
    Huang S; Xu B; Liu Y
    Biochem Biophys Res Commun; 2022 May; 603():13-20. PubMed ID: 35276458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Synuclein phase separation and amyloid aggregation are modulated by C-terminal truncations.
    Huang S; Mo X; Wang J; Ye X; Yu H; Liu Y
    FEBS Lett; 2022 Jun; 596(11):1388-1400. PubMed ID: 35485974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.
    Coskuner-Weber O; Uversky VN
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of α-synuclein conformation ensemble toward amyloid fibril via liquid-liquid phase separation (LLPS) as investigated by dynamic nuclear polarization-enhanced solid-state MAS NMR.
    Takamuku M; Sugishita T; Tamaki H; Dong L; So M; Fujiwara T; Matsuki Y
    Neurochem Int; 2022 Jul; 157():105345. PubMed ID: 35500664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myricetin Inhibits α-Synuclein Amyloid Aggregation by Delaying the Liquid-to-Solid Phase Transition.
    Xu B; Mo X; Chen J; Yu H; Liu Y
    Chembiochem; 2022 Aug; 23(16):e202200216. PubMed ID: 35657723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct higher-order α-synuclein oligomers induce intracellular aggregation.
    Illes-Toth E; Ramos MR; Cappai R; Dalton C; Smith DP
    Biochem J; 2015 Jun; 468(3):485-93. PubMed ID: 25851527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis.
    Gadhe L; Sakunthala A; Mukherjee S; Gahlot N; Bera R; Sawner AS; Kadu P; Maji SK
    Biophys Chem; 2022 Feb; 281():106736. PubMed ID: 34923391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manganese promotes α-synuclein amyloid aggregation through the induction of protein phase transition.
    Xu B; Huang S; Liu Y; Wan C; Gu Y; Wang D; Yu H
    J Biol Chem; 2022 Jan; 298(1):101469. PubMed ID: 34871547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The remarkable conformational plasticity of alpha-synuclein: blessing or curse?
    Deleersnijder A; Gerard M; Debyser Z; Baekelandt V
    Trends Mol Med; 2013 Jun; 19(6):368-77. PubMed ID: 23648364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of Noradrenaline to Native and Intermediate States during the Fibrillation of α-Synuclein Leads to the Formation of Stable and Structured Cytotoxic Species.
    Singh P; Bhat R
    ACS Chem Neurosci; 2019 Jun; 10(6):2741-2755. PubMed ID: 30917654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Synuclein aggregation nucleates through liquid-liquid phase separation.
    Ray S; Singh N; Kumar R; Patel K; Pandey S; Datta D; Mahato J; Panigrahi R; Navalkar A; Mehra S; Gadhe L; Chatterjee D; Sawner AS; Maiti S; Bhatia S; Gerez JA; Chowdhury A; Kumar A; Padinhateeri R; Riek R; Krishnamoorthy G; Maji SK
    Nat Chem; 2020 Aug; 12(8):705-716. PubMed ID: 32514159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The (un)structural biology of biomolecular liquid-liquid phase separation using NMR spectroscopy.
    Murthy AC; Fawzi NL
    J Biol Chem; 2020 Feb; 295(8):2375-2384. PubMed ID: 31911439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease.
    Tóth G; Gardai SJ; Zago W; Bertoncini CW; Cremades N; Roy SL; Tambe MA; Rochet JC; Galvagnion C; Skibinski G; Finkbeiner S; Bova M; Regnstrom K; Chiou SS; Johnston J; Callaway K; Anderson JP; Jobling MF; Buell AK; Yednock TA; Knowles TP; Vendruscolo M; Christodoulou J; Dobson CM; Schenk D; McConlogue L
    PLoS One; 2014; 9(2):e87133. PubMed ID: 24551051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.